Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation.

Higgins, P J

Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation. [electronic resource] - Cancer letters Jan 1994 - 167-75 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0304-3835

10.1016/0304-3835(94)90394-8 doi


Alkaline Phosphatase--metabolism
Butyrates
Butyric Acid
Cell Adhesion--drug effects
Cell Count--drug effects
Cell Differentiation--drug effects
Colorectal Neoplasms--metabolism
Electrophoresis, Gel, Two-Dimensional
Epithelial Cells
Erythrocytes--cytology
Humans
Mucins--metabolism
Neoplasm Proteins--metabolism
Plasminogen Activator Inhibitor 1--physiology
Precipitin Tests
Tumor Cells, Cultured
Up-Regulation--physiology